Machine Learning and Radiogenomics: Lessons Learned and Future Directions

被引:41
|
作者
Kang, John [1 ]
Rancati, Tiziana [2 ]
Lee, Sangkyu [3 ]
Oh, Jung Hun [3 ]
Kerns, Sarah L. [1 ]
Scott, Jacob G. [4 ,5 ]
Schwartz, Russell [6 ,7 ]
Kim, Seyoung [6 ]
Rosenstein, Barry S. [8 ,9 ]
机构
[1] Univ Rochester, Med Ctr, Dept Radiat Oncol, Rochester, NY 14642 USA
[2] Fdn IRCCS, Ist Nazl Tumori, Prostate Canc Program, Milan, Italy
[3] Mem Sloan Kettering Canc Ctr, Dept Med Phys, New York, NY 10021 USA
[4] Cleveland Clin, Dept Translat Hematol & Oncol Res, Cleveland, OH 44106 USA
[5] Cleveland Clin, Dept Radiat Oncol, Cleveland, OH 44106 USA
[6] Carnegie Mellon Sch Comp Sci, Computat Biol Dept, Pittsburgh, PA USA
[7] Carnegie Mellon Univ, Dept Biol Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA
[8] Icahn Sch Med Mt Sinai, Dept Radiat Oncol, New York, NY 10029 USA
[9] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA
来源
FRONTIERS IN ONCOLOGY | 2018年 / 8卷
基金
美国国家卫生研究院;
关键词
statistical genetics and genomics; radiation oncology; computational genomics; precision oncology; machine learning in radiation oncology; big data; predictive modeling; GENOME-WIDE ASSOCIATION; MODULATED RADIATION-THERAPY; CELL LUNG-CANCER; VARIABLE IMPORTANCE MEASURES; BAYESIAN NETWORK APPROACH; SUPPORT VECTOR MACHINES; LINEAR-QUADRATIC MODEL; GENE-GENE INTERACTIONS; RANDOM FORESTS; BREAST-CANCER;
D O I
10.3389/fonc.2018.00228
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Due to the rapid increase in the availability of patient data, there is significant interest in precision medicine that could facilitate the development of a personalized treatment plan for each patient on an individual basis. Radiation oncology is particularly suited for predictive machine learning (ML) models due to the enormous amount of diagnostic data used as input and therapeutic data generated as output. An emerging field in precision radiation oncology that can take advantage of ML approaches is radiogenomics, which is the study of the impact of genomic variations on the sensitivity of normal and tumor tissue to radiation. Currently, patients undergoing radiotherapy are treated using uniform dose constraints specific to the tumor and surrounding normal tissues. This is suboptimal in many ways. First, the dose that can be delivered to the target volume may be insufficient for control but is constrained by the surrounding normal tissue, as dose escalation can lead to significant morbidity and rare. Second, two patients with nearly identical dose distributions can have substantially different acute and late toxicities, resulting in lengthy treatment breaks and suboptimal control, or chronic morbidities leading to poor quality of life. Despite significant advances in radiogenomics, the magnitude of the genetic contribution to radiation response far exceeds our current understanding of individual risk variants. In the field of genomics, ML methods are being used to extract harder-to-detect knowledge, but these methods have yet to fully penetrate radiogenomics. Hence, the goal of this publication is to provide an overview of ML as it applies to radiogenomics. We begin with a brief history of radiogenomics and its relationship to precision medicine. We then introduce ML and compare it to statistical hypothesis testing to reflect on shared lessons and to avoid common pitfalls. Current ML approaches to genome-wide association studies are examined. The application of ML specifically to radiogenomics is next presented. We end with important lessons for the proper integration of ML into radiogenomics.
引用
收藏
页数:21
相关论文
共 50 条
  • [1] LESSONS LEARNED AND FUTURE-DIRECTIONS
    ELIOT, RS
    [J]. AMERICAN HEART JOURNAL, 1988, 116 (02) : 682 - 686
  • [2] HPC lessons learned and future directions
    Lane, S. N.
    [J]. BRIDGE MAINTENANCE, SAFETY, MANAGEMENT AND LIFE-CYCLE OPTIMIZATION, 2010, : 2909 - 2914
  • [3] Perioperative frailty: lessons learned and future directions
    Adeleke, Ibukunoluwa
    Blitz, Jeanna
    [J]. CURRENT OPINION IN ANESTHESIOLOGY, 2021, 34 (03) : 373 - 380
  • [4] FUTURE DIRECTIONS: LESSONS LEARNED AND NEXT STEPS
    Pynoos, J.
    [J]. GERONTOLOGIST, 2011, 51 : 378 - 378
  • [5] Preparing Houston: Lessons learned, future directions
    Madjid, M
    Mirhaji, P
    Lillibridge, S
    Casscells, W
    [J]. SENSORS, AND COMMAND, CONTROL, COMMUNICATIONS, AND INTELLIGENCE (C3I) TECHNOLOGIES FOR HOMELAND DEFENSE AND LAW ENFORCEMENT II, 2003, 5071 : 139 - 145
  • [6] Lessons learned, future directions and issues for GBC
    Cole, RJ
    [J]. BUILDING RESEARCH AND INFORMATION, 2001, 29 (05): : 355 - 373
  • [7] Anthrax bioterrorism: Lessons learned and future directions
    Hughes, JM
    Gerberding, JL
    [J]. EMERGING INFECTIOUS DISEASES, 2002, 8 (10) : 1013 - 1014
  • [8] Cancer chemoprevention: lessons learned and future directions
    Brenner, DE
    Gescher, AJ
    [J]. BRITISH JOURNAL OF CANCER, 2005, 93 (07) : 735 - 739
  • [9] Panel Discussion: Lessons Learned and Future Directions
    Smith, Anthony J.
    [J]. JOURNAL OF ENDODONTICS, 2014, 40 (04) : S86 - S89
  • [10] Cancer Prevention: Lessons Learned and Future Directions
    Dunn, Barbara K.
    Kramer, Barnett S.
    [J]. TRENDS IN CANCER, 2016, 2 (12): : 713 - 722